These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2906393

  • 1. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D.
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
    [Abstract] [Full Text] [Related]

  • 2. Involvement of peripheral dopaminergic mechanisms in the action of a 2-piperazinotetralin (P-11) with hypotensive activity.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D.
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):559-62. PubMed ID: 2906394
    [Abstract] [Full Text] [Related]

  • 3. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H.
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [Abstract] [Full Text] [Related]

  • 4. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ, Hodgson WC, Sutherland SK.
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [Abstract] [Full Text] [Related]

  • 6. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Mar; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 7. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM, Wu BN, Ho WC, Hong SJ, Chen SJ, Lin YT, Chen IJ.
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [Abstract] [Full Text] [Related]

  • 8. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
    Mutafova-Iambolieva V, Staneva-Stoĭcheva D.
    Eksp Med Morfol; 1985 Apr; 24(1):8-12. PubMed ID: 2992908
    [No Abstract] [Full Text] [Related]

  • 9. [Difference of tolerances to isoprenaline between tracheal and vascular smooth muscles and cardiac conduction system in guinea pigs].
    Zhao SJ, Sun GL, Cao YS.
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):210-3. PubMed ID: 1965090
    [Abstract] [Full Text] [Related]

  • 10. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E.
    Arzneimittelforschung; 1984 May; 34(3):270-6. PubMed ID: 6145430
    [Abstract] [Full Text] [Related]

  • 11. [Hypotensive and antihypertensive activity of a newly synthesized derivative of 2-aminotetralin].
    Raĭnova L, Georgieva A, Staneva-Stoĭcheva D.
    Eksp Med Morfol; 1978 May; 17(1):37-43. PubMed ID: 25170
    [Abstract] [Full Text] [Related]

  • 12. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL, Liou SF, Liang JC, Huang YC, Chiang LC, Wu JR, Lin YT, Chen IJ.
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 Jan; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 14. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ, Yeh JL, Lo YC, Sheu SH, Lin YT.
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of the beta-adrenoceptors of guinea-pig, rabbit and rat trachea.
    Rajani AP, Shah DS, Gulati OD.
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):190-8. PubMed ID: 203236
    [Abstract] [Full Text] [Related]

  • 16. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
    Kubo K, Ikeda J, Nakamura J, Nakamizo N.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
    [Abstract] [Full Text] [Related]

  • 17. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
    Lin YT, Wu BN, Horng CF, Huang YC, Hong SJ, Lo YC, Cheng CJ, Chen IJ.
    Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
    [Abstract] [Full Text] [Related]

  • 18. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W, Nakagawa Y, Mitomi A, Imai S.
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
    [Abstract] [Full Text] [Related]

  • 19. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 May; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

  • 20. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW, Lebel W, Weeks R.
    J Cardiovasc Pharmacol; 1984 May; 6(1):142-50. PubMed ID: 6199597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.